Now, researchers at the University of Tokyo have revealed how influenza A viruses are able to more effectively infect their hosts. The findings, published in the journal Nature Microbiology, could lead to new ways to prevent and treat influenza infections.
The researchers found that influenza A viruses use a protein called hemagglutinin (HA) to bind to receptors on the surface of host cells. This binding is essential for the virus to enter the cell and begin replicating.
The researchers also found that HA can bind to different types of receptors, depending on the strain of influenza A virus. This flexibility allows the virus to infect a wide range of hosts, including humans, birds, and pigs.
The findings suggest that HA could be a potential target for new influenza vaccines. By designing vaccines that target HA, we could prevent the virus from binding to host cells and replicating. This could lead to more effective protection against influenza infection.
The researchers say that their findings also provide new insights into the evolution of influenza A viruses. The flexibility of HA allows the virus to adapt to new hosts and environments, which contributes to its success as a pathogen.
"Our findings provide a better understanding of how influenza A viruses infect their hosts," said Dr. Yoshihiro Kawaoka, a professor at the University of Tokyo and one of the lead authors of the study. "This knowledge could lead to new ways to prevent and treat influenza infections."
Influenza A viruses are responsible for a significant amount of morbidity and mortality worldwide. Each year, they cause an estimated 1 billion infections and over 500,000 deaths. While there are vaccines available to protect against influenza infection, these vaccines are not always effective, as the virus is constantly evolving.
The findings of this study could lead to the development of more effective influenza vaccines and treatments, which could have a major impact on public health.
